TP53 and neoplasm: The first p53 recombinant adenovirus was reported by Zhang et al., who introduced WT p53 by Ad5CMV-p53 into four human NSCLC cell lines, in order to show the promising tumor-inhibiting effects of p53 gene therapy [8].